PLURISTEM THERAPEUTICS INC·4

Sep 10, 4:46 PM ET

Aberman Zami 4

4 · PLURISTEM THERAPEUTICS INC · Filed Sep 10, 2020

Insider Transaction Report

Form 4
Period: 2020-09-10
Aberman Zami
DirectorCEO & Co. Chairman
Transactions
  • Award

    Restricted Stock Units

    2020-09-10+500,000993,973 total
  • Award

    Restricted Stock Units

    2020-09-10+500,0001,493,973 total
Holdings
  • Common Stock

    (indirect: By Rose Hitech Ltd.)
    11,140
Footnotes (4)
  • [F1]Each RSU represents a contingent right to receive one share of the Issuer's common stock.
  • [F2]The shares vest over four years as follows: 12.5% shall vest on the 6 month anniversary of the date of grant and the remaining shares vest in 14 equal installments every 3 months thereafter.
  • [F3]The shares vest in full upon milestone achievement of increasing market capitalization of the Issuer's common stock on the Nasdaq Capital Market to $550 million within no more than 3 years from the date of grant.
  • [F4]Such number of shares of common stock have been adjusted to reflect the reverse stock split that occurred on July 25, 2019.

Documents

1 file
  • 4
    ownership.xmlPrimary

    OWNERSHIP DOCUMENT